[Explanation] Recently, the reporter learned from the Henan Provincial Medical Security Bureau that at present, Henan has temporarily included 14 medical institution preparations and 6 Chinese patent medicines used for the prevention and treatment of the new crown virus into the basic medical insurance payment scope of Henan Province.

　　[Explanation] On the afternoon of January 4, the reporter came to Zhengzhou Hospital of Traditional Chinese Medicine. The payers and medicine pickers lined up in the outpatient hall in an orderly manner. Among them, there were not a few of them who bought Golden Arctium Qingying Granules for the prevention and treatment of the new crown virus.

　　[Concurrent] Citizen Mr. Wang

　　This medicine is very bitter. As the saying goes, good medicine tastes bitter. I feel that this medicine has helped me a lot.

After taking this medicine, I can feel obvious relief from sore throat, shortness of breath and chest tightness (symptoms) and I feel faster.

　　[Concurrent] Bai Mingxue, Director of the Preparation Office of Zhengzhou Hospital of Traditional Chinese Medicine

　　When people are at home and feel infected with the new crown, they should go to the hospital in time, or go to a clinic or medical institution to see a doctor. We must distinguish when using (medicine).

Jindou Qingye Granules are used to treat wind-heat-damp new coronavirus infection, which is mainly characterized by fever, cough, red tongue, yellow and thick tongue coating.

　　[Explanation] Bai Mingxue, Director of the Preparation Office of Zhengzhou Hospital of Traditional Chinese Medicine, introduced that Jindou Qingye Granules was developed by the hospital's expert group of Chinese medicine treatment, combined with the characteristics of this epidemic and the current seasonal climate in Henan, urgent research and discussion, and combined with clinical experience.

　　[Concurrent] Bai Mingxue, Director of the Preparation Office of Zhengzhou Hospital of Traditional Chinese Medicine

　　(Jindou Qingye Granules) has been produced after being approved by our Provincial Food and Drug Administration, and has basically produced about 100,000 copies so far, and there is no problem with the current supply.

And this drug has (temporarily) entered our provincial and municipal medical insurance. If it is an inpatient, it will be reimbursed 90%, and if it is an outpatient, it will be paid proportionally.

　　[Explanation] In order to actively respond to the new crown epidemic, give full play to the unique advantages of traditional Chinese medicine in disease prevention, diagnosis, treatment and rehabilitation, and further improve the level of drug protection for insured personnel, with the approval of the National Medical Security Administration, Henan will use Jinduiqing for the prevention and treatment of new crown virus 14 kinds of medical institution preparations such as epidemic granules and 6 kinds of Chinese patent medicines such as Qingshi granules are temporarily included in the province's basic medical insurance and work-related injury insurance payment scope.

　　[Explanation] The reporter learned from many traditional Chinese medicine hospitals in Zhengzhou, Anyang, Nanyang and other cities in Henan that they currently have sufficient preparations for the prevention and treatment of the new coronavirus.

The drugs temporarily included this time are managed as Class B drugs, and the down payment ratio is 10%.

The medical insurance fund will not pay for preparations adjusted and used beyond the prescribed time limit and scope.

The payment period ends on March 31, 2023.

　　[Concurrent] Anyang Hospital of Traditional Chinese Medicine preparation room staff

　　Now (after all, Anyang City has passed the high-incidence period), the usage is not as large as it was at the beginning, and the (current) reserves are sufficient.

　　Reporter Li Chaoqing reported from Zhengzhou, Henan

Editor in charge: [Ji Xiang]